Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Davide Lorenzo Bettini
Institutions:
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia,
University of Brescia
Observed institutions:
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia,
University of Brescia
ORCID:
0009-0005-2356-6511
Observed ORCID:
0009-0005-2356-6511
OpenAlex ID:
A5123033690
Chemo–immunotherapy with cisplatin and nivolumab as second-line approach in metastatic adrenocortical carcinoma
2026
·
Marta Laganà
, Sara Rodella
, et al.
·
European Journal of Endocrinology
·
4
Prognostic role of pretreatment [18F]FDG PET/CT in patients affected by adrenocortical carcinoma and treated with chemotherapy
2026
·
Francesco Dondi
, Davide Lorenzo Bettini
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
1
PDF
Quality of life questionnaire development and validation for adrenocortical carcinoma patients
2026
·
Marta Laganà
, Deborah Cosentini
, et al.
·
European Journal of Endocrinology
·
1
Antineoplastic effect of block-and-replace strategy for managing hypercortisolism caused by adrenal cortical carcinoma
2026
·
Davide Lorenzo Bettini
, Sara Rodella
, et al.
·
JCEM Case Reports
Impact of baseline nutritional and inflammatory markers on safety and efficacy of immune checkpoint inhibitors in cancer patients: a retrospective, monocentric study
2026
·
Alice Baggi
, Davide Smussi
, et al.
·
Discover Oncology
Show more works
View as search
Works count:
5
Citation count:
6
H-index:
1
I10-index:
Year
Topic
Type